IRadimed Corporation
IRMD
$69.57
-$1.12-1.58%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 5.77M | 4.69M | 5.15M | 5.05M | 4.90M |
Total Depreciation and Amortization | 207.50K | 194.10K | 194.90K | 197.60K | 199.10K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 309.20K | 1.49M | 433.40K | 743.30K | -899.80K |
Change in Net Operating Assets | 1.46M | -2.08M | 212.10K | 3.13M | 2.44M |
Cash from Operations | 7.75M | 4.29M | 5.99M | 9.12M | 6.64M |
Capital Expenditure | -2.64M | -3.70M | -2.79M | -3.81M | -1.13M |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -188.00K | -219.80K | -266.60K | -201.50K | -135.50K |
Cash from Investing | -2.82M | -3.92M | -3.06M | -4.01M | -1.27M |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -- | -- | 26.30K | 0.00 | 3.30K |
Repurchase of Common Stock | -96.00K | -116.30K | -542.50K | -17.80K | -63.90K |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -2.16M | -2.16M | -1.90M | -1.90M | -1.90M |
Other Financing Activities | -- | -- | -- | -- | -- |
Cash from Financing | -2.26M | -2.28M | -2.42M | -1.92M | -1.96M |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 2.66M | -1.90M | 512.90K | 3.19M | 3.41M |